Experimental design of a liposomal lipid system: A potential strategy for paclitaxel-based breast cancer treatment

Colloids and Surfaces B: Biointerfaces

Volumn 136, Issue , 2015, Pages 553-561

  Barbosa, Marcos V ^a   Monteiro, Liziane O F ^b   Carneiro, Guilherme ^a   Malagutti, Andréa R ^a   Vilela, José M C ^c   Andrade, Margareth S ^c   Oliveira, Mônica C ^b   Carvalho Junior, Alvaro D ^a   Leite, Elaine A ^a,b  

^a UNIVERSIDADE FEDERAL DOS VALES DO JEQUITINHONHA E MUCURI   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FUNDAÇÃO CENTRO TECNOLÓGICO DE MINAS GERAIS   (Brazil)

Author keywords

Folate; Liposomes; Paclitaxel; PH sensitivity; Targeted drug delivery

Indexed keywords

CELL CULTURE; CELLS; CYTOLOGY; CYTOTOXICITY; DISEASES; ENZYME INHIBITION; LIPOSOMES; PH SENSORS; TUMORS;

BREAST CANCER TREATMENT; DRUG DELIVERY SYSTEM; FOLATE; PACLITAXEL; PARENTERAL ADMINISTRATION; PH SENSITIVITY; PHYSICOCHEMICAL PROPERTY; TARGETED DRUG DELIVERY;

PATIENT TREATMENT;

FOLIC ACID; LIPOSOME; MACROGOL; PACLITAXEL; LIPID;

ARTICLE; BREAST CANCER CELL LINE; BREAST METASTASIS; CANCER THERAPY; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; EXPERIMENTAL DESIGN; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; PRIORITY JOURNAL; ZETA POTENTIAL; BREAST NEOPLASMS;

BREAST NEOPLASMS; HUMANS; LIPIDS; LIPOSOMES; PACLITAXEL;

EID: 84943781047     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.09.055     Document Type: Article

References (41)

1. Couvreur P., Vauthier C. Pharm. Res. 2006, 23:1417.
2. Ferreira D.S., Lopes S.C.A., Franco M.S., Oliveira M.C. Ther. Deliv. 2013, 4:1099.
3. Singla A.K., Garg A., Aggarwal D. Int. J. Pharm. 2002, 235:179.
4. Koudelka S., Turánek J. J. Control. Release 2012, 163:322.
5. Yared J.A., Tkaczuk K.H. Drug Des. Dev. Ther. 2012, 6:371.
6. Chakravarthi S.S., Robinson D.H. Int. J. Pharm. 2011, 209:111.
7. Surapaneni M.S., Das S.K., Das N.G. ISRN Pharmacol. 2012, 2012:623139.
8. Xu X., Wang L., Xu H., Huang X., Qian Y., Xiang J. Asian Pac. J. Cancer Prev. 2013, 14:2591.
9. Crosasso P., Ceruti M., Brusa P., Arpicco S., Dosio F., Cattel L. J. Control. Release 2000, 63:19.
10. Wu J., Liu Q., Lee R.J. Int. J. Pharm. 2006, 316:148.
11. Yang T., Cui F., Choi M., Lin H., Chung S., Shim C., Kim D. Drug Deliv. 2007, 14:301.
12. Heney M., Alipour M., Vergidis D., Omri A., Mugabe C., Th'ng J., Suntres Z. Can. J. Physiol. Pharmacol. 2010, 88:1172.
13. Kan P., Tsao C., Wang A., Su W., Liang H. J. Drug Deliv. 2011, 2011:629234.
14. Cai L., Wang X., Wang W., Qiu N., Wen J., Duan X., Li X., Chen X., Yang L., Qian Z., Wei Y., Chen L. Int. J. Nanomed. 2012, 7:4499.
15. Videira M.A., Arranja A.G., Gouveia L.F. Eur. J. Pharm. Sci. 2013, 49:302.
16. Torchilin W.P. Eur. J. Pharm. Biopharm. 2009, 71:432.
17. Wang F., Chen Y., Zhang D., Zhang Q., Zheng D., Hao L., Liu Y., Duan C., Jia L., Liu G. Int. J. Nanomed. 2012, 7:325.
18. Chaudhury A., Das S. Curr. Pharm. Biotechnol. 2015, 16:333.
19. Parker N., Turk M.J., Westrick E., Lewis J.D., Low P.S., Leamon C.P. Anal. Biochem. 2005, 338:284.
20. Jhaveri M.S., Rait A.S., Chung K.N., Trepel J.B., Chang E.H. Mol. Cancer. Ther. 2004, 3:1505.
21. Frézard F., Schettini D.A., Rocha O.G.F., Demicheli C. Quim. Nova 2005, 28:511.
22. A.D. Bangham, M.M. Standish, J.C. Watkins, 13 (1965) 238.
23. Barbosa M.V., Monteiro L.F., Malagutti A.R., Oliveira M.C., Carvalho-Junior A.D., Leite E.A. J. Braz. Chem. Soc. 2015, 26(1338).
24. Mosmann T. J. Immunol. Methods 1983, 65:55.
25. Benhabbour S.R., Luft J.C., Kim D., Jain A., Wadhwa S., Parrott M.C., Liu R., DeSimone J.M., Mumper R.J. J. Control. Release 2012, 158:63.
26. Carvalho Júnior A.D., Vieira F.P., Melo V.J., Lopes M.T., Silveira J.N., Ramaldes G.A., Garnier-Suillerot A., Pereira-Maia E.C., Oliveira M.C. Braz. J. Med. Biol. Res. 2007, 20:1149.
27. Leite E.A., Souza C.M., Carvalho-Júnior A.D., Coelho L.G., Lana A.M., Cassali G.D., Oliveira M.C. Int. J. Nanomed. 2012, 7:5259.
28. Lopes S.C.A., Novais M.V.M., Teixeira C.S., Honorato-Sampaio K., Pereira M.T., Ferreira L.A.M., Braga F.C., Oliveira M.C. Biomed. Res. Int. 2013, 2013:467147.
29. Sacchetti C., Motamedchaboki K., Magrini A., Palmieri G., Mattei M., Bernardini S., Rosato N., Bottini N., Bottini M. ACS Nano. 2013, 7:1974.
30. Cho K., Wang X., Nie S., Chen Z., Sin D.M. Clin. Cancer Res. 2008, 14:1310.
31. Meng S., Su B., Li W., Ding Y., Tang L., Zhou W., Song Y., Li H., Zhou C. Nanotechnology. 2010, 21:415103.
32. Sawant R.R., Torchilin V.P. AAPS J. 2012, 14:303.
33. De Barros A.L.B., Mota L.G., Soares D.C.F., Souza C.M., Cassali G.D., Oliveira M.C., Cardoso V.N. J. Biomed. Nanotechnol. 2013, 9:1636.
34. Fertsch-Gapp S., Semmler-Behnke M., Wenk A., Kreyling W.G. Inhalation Toxicol. 2011, 23:468.
35. Wolfram J., Suri J., Yang Y., Shen J., Celia C., Fresta M., Ferrari M. Colloids Surf. B Biointerfaces 2014, 114:114.
36. Ishida T., Okada Y., Kobayashi T., Kiwada H. Int. J. Pharm. 2006, 309:94.
37. Nejatpour M., Bayat Z., Mahdizadeh S.J. J. Chem. Pharm. Res. 2011, 3:253.
38. Gu Q., Xing J.Z., Huang M., Zhang X., Chen J. J. Biomater. Appl. 2013, 28:298.
39. Fattal E., Couvreur P., Dubernet C. Adv. Drug Deliv. Rev. 2004, 53:931.
40. Sudimack J., Lee R.J. Adv. Drug Deliv. Rev. 2000, 41:147.
41. Stevens P.J., Lee R.J. Anticancer Res. 2003, 23:4927.